Zevra Therapeutics Announces Details for Q3 2026 Financial Results Call
Globe Newswire•20/10/2026•07:30 ET
0
Key Highlights
- ➤Q3 2026 results scheduled for November 3 after market close
- ➤Conference call and webcast set for 4:30 p.m. ET November 3
- ➤Zevra markets a U.S. lead product for Niemann-Pick disease type C
BOSTON, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases, today announced it will report corporate and financial results for the third quarter on Tuesday, November 3, 2026, via a news release after the market close, and will host a conference call/audio webcast at 4:30 p.m. ET that day.
A link to the audio webcast will be accessible on the “Events & Presentations” page in the Investor Relations section of Zevra’s website at investors.zevra.com.
Get started
Create a free account to read the full story.